Literature DB >> 1987225

In-hospital mortality after balloon aortic valvuloplasty: frequency and associated factors.

D R Holmes1, R A Nishimura, G S Reeder.   

Abstract

Percutaneous balloon aortic valvuloplasty has been accompanied by significant early periprocedural morbidity and mortality. Identification of factors associated with increased mortality might allow for improved selection of patients. The Mansfield Scientific Balloon Aortic Valvuloplasty Registry was analyzed to identify the frequency of in-hospital death and the factors associated with it. Of 492 patients undergoing the procedure, 37 (7.5%) died during the hospital stay in which valvuloplasty was performed. Twenty-four of these patients died within the first 24 h and the remainder died within 7 days after the procedure. There were significant differences in baseline clinical and hemodynamic characteristics as well as procedural and postprocedural variables between patients dying and those surviving the in-hospital period. Multivariate analysis identified four factors associated with increased mortality: 1) the occurrence of a procedure-related complication, 2) a lower initial left ventricular systolic pressure, 3) a smaller final aortic valve area, and 4) a lower baseline cardiac output. Thus, baseline hemodynamic, procedural and postprocedural variables and complications can be identified that are associated with increased mortality.

Entities:  

Mesh:

Year:  1991        PMID: 1987225     DOI: 10.1016/0735-1097(91)90726-p

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  2 in total

1.  Balloon aortic valvuloplasty as a bridge to aortic valve replacement in a patient with severe calcific aortic stenosis.

Authors:  B M Swinkels; W Jaarsma; L Relik-van Wely; H A van Swieten; J M P G Ernst; H W M Plokker
Journal:  Neth Heart J       Date:  2003-03       Impact factor: 2.380

2.  Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT).

Authors:  Peter Bramlage; Justus Strauch; Holger Schröfel
Journal:  BMC Cardiovasc Disord       Date:  2014-11-18       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.